TrialBritish journal of cancer1996

Multicentre phase II pharmacological evaluation of rhizoxin. Eortc early clinical studies (ECSG)/pharmacology and molecular mechanisms (PAMM) groups.

H L McLeod et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.